Faculty of Biology, Medicine and Health

The University of Manchester

  Characterisation of how pro-peptide regions of collagen control extracellular matrix homeostasis, in health and musculoskeletal diseases

  , ,  Applications accepted all year round  Self-Funded PhD Students Only

About the Project

Collagen-I (‘collagen’ from hereon) is the most abundant protein in the human body (circa 25% of total protein mass), providing structure to organs with very different functions (e.g. tendons vs lungs). Collagen deposition is a tightly controlled process; dysregulation underpins many pathologies and age-related conditions, including fibrosis, heart disease, and poor wound-healing. Genetic mutations in collagen leads to connective tissue disorders such as osteogenesis imperfecta and Ehlers Danlos syndrome. Despite collagen’s fundamental importance, therapeutics for diseases associated with collagen have been lacking, due to conceptual hurdles in understanding how collagen is assembled/removed. Closing these knowledge gaps forms the basis of this project.

Previously we have found that 1) collagen homeostasis is controlled by the circadian rhythm), 2) protomeric collagen secretion is separately controlled to fibrillogenesis, and 3) enhanced endosomal recycling may drive fibrotic progression. Preliminary data in the lab also indicates a previously uncharacterised function for the propeptide region in regulating collagen-I homeostasis.

Using a combination of CRISPR-Cas9 genome editing (e.g. endogenous protein tagging), protein structural analyses (e.g. crystallography), protein biochemistry (e.g. nanobody screening), in vitro 2D/3D cell culture systems and in vivo mouse models, this PhD project aims to characterise the propeptide region of collagen-I, and further interrogate the molecular mechanisms to how collagen-I homeostasis is regulated.

Training/techniques to be provided

This project will utilise the following techniques (not exhaustive): Mouse models, CRISPR gene knockout/knockin, confocal microscopy, flow cytometry, electron microscopy (EM), protein expression and structure (crystallography, cryo-EM), protein biochemistry, cell culture, primary cell culture, mass spectrometry analyses, biomechanics analyses. 

The student will be trained both in terms of scientific techniques and analytical analyses. They will also have extensive training in scientific writing, poster presentation and oral presentation skills. Students will have access to online training courses and will have ample opportunities to present at internal and external meetings and conferences. 

Entry Requirements

Applicants must have obtained or be about to obtain a First or Upper Second class UK honours degree, or the equivalent qualifications gained outside the UK, in a relevant subject area.

How to Apply

For information on how to apply for this project, please visit the Faculty of Biology, Medicine and Health Doctoral Academy website (https://www.bmh.manchester.ac.uk/study/research/apply/). Informal enquiries may be made directly to the primary supervisor. On the online application form select the PhD Cell Matrix Biology & Regenerative Medicine.

For international students, we also offer a unique 4 year PhD programme that gives you the opportunity to undertake an accredited Teaching Certificate whilst carrying out an independent research project across a range of biological, medical and health sciences. For more information please visit https://www.bmh.manchester.ac.uk/study/research/international/

Equality, Diversity & Inclusion

Equality, diversity and inclusion is fundamental to the success of The University of Manchester, and is at the heart of all of our activities. The full Equality, diversity and inclusion statement can be found on the website

https://www.bmh.manchester.ac.uk/study/research/apply/equality-diversity-inclusion/

Biological Sciences (4)

Funding Notes

Applications are invited from self-funded students. This project has a Band 2 fee.
Details of our different fee bands can be found on our website View Website

References

1) Chang J*, Garva R*, Pickard A*, Yeung C-Y C*, Mallikarjun V, Swift J, Holmes DF, Calverley B, Lu Y, Adamson A, Raymond-Hayling H, Jensen O, Shearer T, Meng QJ, Kadler KE. Circadian control of the secretory pathway maintains collagen homeostasis. (*Equal contribution) Nature Cell Biology, 2020 Jan 6; 22:74-86
2) Pickard A, Calverley BC, Chang J, Garva R, Lu Y, Kadler KE. Discovery of re-purposed drugs that slow SARS-CoV-2 replication in human cells. PLOS Pathogens, 2021; 17(9), 31009840.
3) Zacharchenko T, Kalverda A, Wright SC. Structural basis of Apt48 inhibition of BCL6 BTB-domain. Structure, 2022 Mar 3;396-407.
4) Godwin ARF, Dajani R, Zhang X, Thomson J, Holmes DF, Adamo CS, Sengle G, Sherratt MJ, Roseman AM, Baldock C. Fibrillin microfibril structure identified long-range effects of inherited pathogenic mutations affecting a key regulatory latent TGFb-binding site. Nature Structure. 2023 30:608-618.
5) Lockhart-Cairns MP, Cain SA, Dajani R, Steer R, Thomson J, Alanazi YF, Kielty CM, Baldock C. Latent TGFβ complexes are transglutaminase cross-linked to fibrillin to facilitate TGFβ activation. Matrix Biol. 2022 107:24-39.

Open days



Register your interest for this project



Where will I study?

Search Suggestions
Search suggestions

Based on your current searches we recommend the following search filters.

Faculty of Biology, Medicine and Health

Tackle real world challenges, make a difference, and elevate your career with postgraduate research in the Faculty of Biology, Medicine and Health at Manchester. From biochemistry to neuroscience, cancer sciences to medicine, audiology to mental health and everything in between, we offer a wide range of postgraduate research projects, programmes and funding which will allow you to immerse yourself in an area of research you’re passionate about.

Why study at Faculty of Biology, Medicine and Health?

Ranked the best place to live in the UK (The Economist Global Liveability Index, 2022), Manchester boasts world-class culture, iconic sports, a thriving music and food scene, and much more. It’s not just a place to research, it’s a place to call home.

Experience PhD life as part of a diverse postgraduate research community of more than 1,000 postgraduate researchers at the 29th most international university in the world (Times Higher Education, 2023).

With 93% of research activity at the University rated as ‘world-leading’ or ‘internationally excellent’ (Research Impact Framework, 2021), you’ll get the chance to have an impact on global health and science challenges.

1000+

postgraduate students

97

PhDs

6

ranked in UK - QS (2025)

Manchester  United Kingdom

main campus

Upcoming Open Days & Webinars

16

Sep 2024

The University of Manchester

Postgraduate Research Webinars - Biology, Medicine and Health

 Manchester

25

Sep 2024

The University of Manchester

Postgraduate Research Open Day - Biology, Medicine and Health

 Manchester


About Faculty of Biology, Medicine and Health

At Manchester, postgraduate researchers are at the heart of our mission to tackle pressing global challenges in biological, medical and healthcare sciences - and you could be too.

By choosing Manchester for your postgraduate research, you’ll be joining a university with an exceptional research reputation, where 93% of research is world-leading or internationally excellent (REF, 2021) and where your work will have real-world impact.

You’ll research in world-class facilities alongside leading experts at the forefront of innovation, collaborating across disciplines to pioneer new treatments, advance scientific knowledge, and improve healthcare globally.

Supported by our dedicated Doctoral Academy and strong industry links, you'll experience PhD life in a vibrant, welcoming and diverse postgraduate research community.

And you’ll leave with the specialist knowledge, research experience and transferable skills that will shape your future in academia, research or industry.


Main campus

The University of Manchester

Manchester

North West

United Kingdom

PhD saved sucessfully

A novel role in mitochondrial homeostasis for the anti-ageing factor RBBP5

The mitochondrion has evolved from the endosymbiotic interaction of an alpha-proteobacterium and an archaeon. One major event during this evolution was the transferring of genes from the symbiont to the host. Read more
More details

Bioinspired Nanomaterials Based Miniaturised Soft Robots for High Precision Regiospecific Drug Delivery to Malignant Tumours

Cancer is one of the top global public health challenges, estimated to have caused 10M deaths (2020) according to WHO. Throughout the years, standardised therapeutic protocols have been developed and evolved for the treatment of various types of cancers. Read more
More details

Cell-matrix interface engineering for regenerative medicine applications and disease modelling

Dr. Mahetab Amer is seeking motivated students with backgrounds in tissue engineering, cell biology, materials science, or related fields to join her dynamic, multidisciplinary research group at the Division of Cell Matrix Biology and Regenerative Medicine, University of Manchester. Read more
More details

Chaperones and the response to protein misfolding stress

Misfolded proteins are usually refolded to their functional conformations or degraded by quality control mechanisms. When misfolded proteins evade quality control, they form aggregates that are sequestered to specific sites within cells. Read more
More details

Circadian clock control of adipocyte metabolism

Obesity is a major public health issue affecting one third of UK adults, and an estimated 2.1 billion individuals worldwide. The role of circadian clock dysfunction in the development of obesity is becoming clear, with disruptive lifestyles (e.g. Read more
More details

Clinical Prediction Modelling under Federated Learning

Clinical prediction models (CPMs) take a set of characteristics about a patient to estimate their risk of an event of interest. Developing CPMs using data that captures observations across multiple clusters (e.g., countries) can increase the robustness and generalisability of CPMs. Read more
More details

Decoding the epigenetic mechanisms of drug resistance in aggressive breast cancers

Breast cancers pose a major health burden to modern world as being the most common cancer in women. Estrogen receptor (ER), the classical marker of 70% these cancers, is the nuclear receptor important for cancer progression. Read more
More details

Defining the molecular mechanisms of leukaemia chemotherapies

Chemotherapies are usually the backbone of cancer treatment for either curative or palliative patient care. Multiple therapies can be used for the same disease, with the choice of drug dependent on parameters such as the patient’s age and fitness. Read more
More details

Defining the role of glycation in extracellular matrix damage in ageing and diabetic skin

In skin, long-lived extracellular matrix (ECM) components in the dermis undergo a form of ageing where damage is accumulated to their protein structures by mechanisms such as glycation, photo-oxidation and protease cleavage, leading to profound changes in tissue architecture and function. Read more
More details

Delineating the IRF6 regulatory network driving periderm formation and function

During development, the ectoderm passes through a series of cell states to produce a self-replenishing, multi-layered epidermis. Initial stratification forms a single-cell layer of flattened periderm cells which act as a barrier to prevent pathological adhesions during embryogenesis. Read more
More details

Diagnostics for FMF patients and carrier survival in pandemics

Background. Familial Mediterranean Fever (FMF) is a rare inherited genetic disease where patients acquire a mutation on the pyrin gene leading to excessive inflammasome activation and excessive inflammation. Read more
More details

Driving phenotypic plasticity and metastasis in small cell lung cancer

Small cell lung cancer (SCLC) is an aggressive malignancy with poor prognosis. Underlying this aggressiveness is intra-tumoural heterogeneity driven by phenotypic plasticity wherein tumour cells transition from a neuroendocrine (NE) to a non-neuroendocrine (non-NE) phenotype. Read more
More details

Dysfunctional antifungal potency of the respiratory mucosa in COPD

Inhalation of Aspergillus fumigatus spores cause >3,000,000 chronic and >200,000 invasive diseases annually worldwide. Invasive aspergillosis carries a 50% mortality rate overall, but mortality rate approaches 100% if diagnosis is delayed or missed and it is >75% in certain cohorts of patients, such as COPD sufferers. Read more
More details

Early life factors in the development of Juvenile idiopathic arthritis

Juvenile idiopathic arthritis (JIA) is an autoimmune inflammatory arthritis with disease onset before the age of 16. Children and young people with this condition develop painful swollen joints and untreated it can lead to long term disability. It may also be associated with comorbid conditions such as uveitis. Read more
More details

Identification and structural analysis of transient interactions in supra-molecular complexes involved in protein synthesis

The aim of this project is to understand the dynamic interactions in the mechanism and control of protein synthesis in eukaryotic cells at the molecular level using hydrogen-deuterium exchange mass spectrometry (HDX-MS), and particularly the role of the eukaryotic translation initiation factors eIF2, eIF5 and eIF2B[1,2]. Read more
More details

Inducing ferroptotic death to kill cancer cells

Ferroptosis is an iron-dependent form of regulated necrotic cell death triggered by oxidative degradation of lipids in membrane bilayers and subsequent irreparable damages to the plasma membrane (1). Read more
More details

Intrinsic mechanisms of axonal regeneration following peripheral nerve injury

Peripheral nerve injury (PNI) is a common consequence of trauma with life-changing implications both physically (loss of limb function) and psychologically (impact on employment, personal relationships and wider wellbeing). Read more
More details

Investigating monogenic disorders of the protein synthesis machinery

Translation of mRNA into proteins is a critical cellular biological process. We recently described a novel human disorder, now called Faundes-Banka Syndrome (FABAS), caused by heterozygous variants in EIF5A1 that encodes a translation factor. Read more
More details

Investigating the cardio-pulmonary impact of airborne nanoplastics

There is growing evidence that humans are exposed to incidental microplastics and nanoplastics (MNPL) particles through inhalation and that the small size of these particles may allow for bioaccumulation and retention in the body. Read more
More details

Mechanistic analysis of neurodevelopmental disorders caused by mutations in the gene RAC1

RAC1 is a signalling protein that regulates many cellular processes and is essential during embryonic development. We recently discovered a novel genetic disease called RAC1-related neurodevelopmental disorder (RAC1-NDD) that results from mutations in the RAC1 gene. Read more
More details

Modelling the ecology and evolution of microbial communities

From the human gut to deep-sea sediments, microbial communities – or microbiomes – colonize virtually every habitat on earth. These microbiomes are central to ecosystem functioning and to host health, and therefore it is essential that we understand how and why they change over time. Read more
More details